Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market…Update-1
Update-1 Five days of selling but looks like routine re-balancing at market highs. NASDAQ leads way down 0.7% Whether it is concerns about Washington or a seasonal buyers strike or even an extended summer vacation who knows? The 3.3% drop in AAPL on App Store ruling did not help. Here are some...
What’s Next for Biotech Stocks? …Update-1
Update-1 3:45P 9/1 FDA issues warning on JAK Inhibitor drug class. ABBV down 7%., PFE and LLY drugs also affected. Small cap rally intact: CRSP,CYRX, VCYT. Quidel (QDEL) up 5.45% on need for more COVID tests. ARKG and XBI up about 1.5%. Mid-caps all green. IBB up 0.96%. Barron's bullish on...
Healthcare Stocks Hit New Highs but Small Caps Lag…Update-2 Cyclicals Rally
Update-2 Powell talks taper as market rises. All indices were up in early trading with NASDAQ up 0.96%.Cyclicals were leading with energy XLE up 3%, industrials XLI up 0.88%, and XLF up 0.9%. A "risk-on" trade was developing with the IWM up 2.5% and the XBI up 3.12% to 132.59. All of our focus...
Large Cap Biopharma Stocks provide Growth and Value…Update-1 8/20
Update-1 8/20 After a choppy week, many smaller caps turn green ! Small cap life science stocks have been in a steady sell-off but the tape looks better today. All of our recent top picks are up: CRSP, CYRX and VCYT. Indicators for momentum are also up: ARKG and XBI. NASDAQ was up 1.19%. I...
Rayno BioBeat #3: Choppy Days are Ahead but Still Looks Bullish…Update-3 vaccine sell-off
8/11/21 2p EDT...A sea of red in most smaller cap biotech stocks but market overall is holding up nicely. The normally stable IBB is down over 3.5% so must be the inclusion of MRNA? BNTX is down 18% to $340! Large cap biopharma is holding up except Pfizer (PFE) is down 3.62% probably related...